Anavex Lifesciences Corpis A Clinical Stagebiopharmaceutical Company Based In New Yorkthecompany Focuses On Developing Targeted Therapies For Central Nervous Systemcnsdisorders Using A Precision Medicineapproachanavex Specializes In Small Moleculetherapeutics Aimed At Conditions Such As Alzheimeraes Diseaseparkinsonaes Diseaseschizophreniaand Rett Syndromethecompany S Primary Offering Is Thesigmaceptora C Discovery Platformwhich Targets Thesigma 1 Receptor To Activatemechanisms That Help Counteract Neurodegenerationoneof Its Key Products Is Anavexa 2 7 Blarcamesinean Oral Small Moleculein Clinical Development For Various Cns Disordersanavex Also Has A Pipelineof Preclinical Candidates Addressing Neuropathic Painepilepsydepressionstrokeand Certain Cancers Anavex Is Committed To Scientific Innovation And Equitableaccess To Therapiesfocusing On Patient Specific Interventions To Optimizetreatment Outcomesthecompany Actively Engages With Thecommunity To Ensureaccess To Its Therapies Oncethey Receiveregulatory Approval
